Joanne Curley - 20 Sep 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
20 Sep 2022
Net transactions value
-$186,211
Form type
4
Filing time
22 Sep 2022, 16:06:39 UTC
Previous filing
08 Sep 2022
Next filing
06 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $6,233 +978 +3.4% $6.37 29,775 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $20,092 -978 -3.3% $20.54 28,797 20 Sep 2022 Direct F1, F2
transaction VERA Class A Common Stock Options Exercise $637 +100 +0.35% $6.37 28,897 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $2,100 -100 -0.35% $21.00 28,797 20 Sep 2022 Direct F1
transaction VERA Class A Common Stock Options Exercise $5,295 +1,828 +6.3% $2.90* 30,625 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $37,430 -1,828 -6% $20.48 28,797 20 Sep 2022 Direct F1, F3
transaction VERA Class A Common Stock Options Exercise $968 +334 +1.2% $2.90* 29,131 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $6,986 -334 -1.1% $20.92 28,797 20 Sep 2022 Direct F1, F4
transaction VERA Class A Common Stock Options Exercise $25,454 +2,314 +8% $11.00 31,111 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $46,838 -2,314 -7.4% $20.24 28,797 20 Sep 2022 Direct F1, F5
transaction VERA Class A Common Stock Options Exercise $111,232 +10,112 +35% $11.00 38,909 20 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $210,375 -10,112 -26% $20.80 28,797 20 Sep 2022 Direct F1, F6
transaction VERA Class A Common Stock Options Exercise $10,010 +910 +3.2% $11.00 29,707 21 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $19,224 -910 -3.1% $21.13 28,797 21 Sep 2022 Direct F1, F7
transaction VERA Class A Common Stock Options Exercise $2,904 +264 +0.92% $11.00 29,061 21 Sep 2022 Direct
transaction VERA Class A Common Stock Sale $5,899 -264 -0.91% $22.35 28,797 21 Sep 2022 Direct F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Options Exercise $0 -1,078 -8.3% $0.000000 11,873 20 Sep 2022 Class A Common Stock 1,078 $6.37 Direct F9
transaction VERA Stock Option (right to buy) Options Exercise $0 -2,162 -4.8% $0.000000 42,436 20 Sep 2022 Class A Common Stock 2,162 $2.90 Direct F10
transaction VERA Stock Options (right to buy) Options Exercise $0 -12,426 -12% $0.000000 90,491 20 Sep 2022 Class A Common Stock 12,426 $11.00 Direct F11
transaction VERA Stock Options (right to buy) Options Exercise $0 -1,174 -1.3% $0.000000 89,317 21 Sep 2022 Class A Common Stock 1,174 $11.00 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.96 to $20.90, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $20.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.87 to $21.00, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.68 to $20.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.06, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.74 to $21.58, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.09 to $22.62, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.
F10 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
F11 1/4 of the shares subject to the option vested on May 13, 2022, and 1/48 of the shares vest monthly thereafter.